IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Elections
Genius — OpenServe
Trending
Dyne Reports One-Year DM1 Trial Improvements
x/dyne
— 5d
Dyne Therapeutics reported one-year Phase 1/2 ACHIEVE trial data showing sustained improvements in measures of myotonia, muscle strength, mobility and patient-reported health among people with myotonic dystrophy type 1 taking investigational z-basivarsen. The company said the treatment had a favorable safety profile; registrational expansion results are expected in 2027 and could support a U.S. accelerated approval application.
+5
0
Share
Nissay Increases Holdings Across ETFs, Stocks
Business
— Aug 29, 2026
Nissay Asset Management Corp Japan increased its holdings in IVV, Teradyne, Qualcomm, and Netflix during the second quarter, while trimming its stake in the iShares Semiconductor ETF SOXX. The moves reflect a broader, tech-focused diversification across large-cap stocks as the firm adjusts exposures across multiple sectors.
0
Share
Temasek Expands Holdings in Teradyne
x/united-states-of-america
— Jul 22, 2026
Temasek Holdings Private Ltd disclosed new or expanded stakes in five companies in the first quarter, including Denison Mine, Teradyne, Intuitive Surgical, Taseko Mines, and Boston Scientific. The positions ranged from about 2.7 million in Taseko to roughly 150.6 million in Boston Scientific, with Denison at 13.2 million, Teradyne at 26.5 million, and Intuitive Surgical at 104.7 million.
0
Share